Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
Abstract
Topical patch preparations that contain a delayed-type hypersensitivity inducer, e.g., 1-dichloro-2,4-dinitrobenzene (DNCB), and methods for using the same are provided. The subject topical patch preparations are made up of an adhesive gel composition that is present on a support, where the adhesive gel composition includes the delayed-type hypersensitivity inducer, a water-soluble polymer gel, water and a water holding agent. In using the subject topical patch preparations, the topical patch preparations are applied to a skin surface of a subject and maintained at the site of application for a period of time sufficient for an effective amount of the delayed-type hypersensitivity inducer to be administered to the subject, where this maintenance period typically does not exceed about 60 minutes. The subject invention finds use in a variety of applications where the administration of a delayed-type hypersensitivity inducer is desired, and is particularly suited for use in the treatment of HIV associated disease conditions, e.g., AIDS.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A topical patch preparation of a delayed-type hypersensitivity inducer, said preparation comprising:
an adhesive gel composition comprising a delayed-type hypersensitivity inducer; and a support.
2 . The topical patch preparation according to claim 1 , wherein said delayed-type hypersensitivity inducer is 1-Chloro-2,4-Dinitrobenzene (DNCB).
3 . The topical patch preparation according to claim 2 , wherein said DNCB is present in said adhesive gel composition in an amount ranging from about 0.01 to 10.0% (w/w).
4 . The topical patch preparation of claim 1 , wherein said adhesive gel composition comprises:
a water-soluble polymer gel; water; and a water retaining agent.
5 . The topical patch preparation according to claim 4 , wherein said water is present in an amount ranging from about 10 to 80% (w/w).
6 . The topical patch preparation according to claim 1 , wherein said adhesive gel composition has a pH ranging from about 4.0 to 7.0.
7 . The topical patch preparation according to claim 1 , wherein said adhesive gel composition further comprises an organic solvent.
8 . The topical patch preparation according to claim 7 , wherein said organic solvent is selected from the group consisting of n-methyl-2-pyrrolidone, polyethylene glycol and crotamiton and combinations thereof.
9 . A topical patch preparation comprising:
(a) an adhesive gel composition having a pH ranging from about 4.0 to 7.0 and comprising:
(i) DNCB in an amount ranging from about 0.01 to 10.0% (w/w);
(ii) a water-soluble polymer gel;
(iii) water in an amount ranging from about 10 to 80% (w/w); and
(iv) a water retaining agent; and
(b) a support.
10 . The topical patch preparation according to claim 9 , wherein said DNCB is present in an amount ranging from about 0.1 to 5.0% (w/w).
11 . The topical patch preparation according to claim 10 , wherein said DNCB is present in an amount ranging from about 0.2 to 3.0% (w/w).
12 . The topical patch preparation according to claim 9 , wherein said water is present in an amount ranging from about 20 to 70% (w/w).
13 . The topical patch preparation according to claim 12 , wherein said water is present in an amount ranging from about 30 to 60% (w/w).
14 . The topical patch preparation according to claim 9 , wherein said pH ranges from about 4.0 to 6.0.
15 . The topical patch preparation according to claim 14 , wherein said adhesive gel composition further comprises an organic solvent.
16 . The topical patch preparation according to claim 15 , wherein said organic solvent is selected from the group consisting of n-methyl-2-pyrrolidone, polyethylene glycol, and crotamiton and combinations thereof.
17 . A topical patch preparation comprising:
(a) an adhesive gel composition having a pH ranging from about 4.0 to 6.0 and comprising:
(i) DNCB in an amount ranging from about 0.2 to 3.0% (w/w);
(ii) a water-soluble polymer gel;
(iii) water in an amount ranging from about 30 to 60% (w/w);
(iv) a water retaining agent; and
(v) an organic cosolvent selected from the group consisting of n-methyl-2-pyrrolidone, polyethylene glycol and crotamiton and combinations thereof;
(b) a support.
18 . A kit for use in transdermal delivery of a delayed-type hypersensitivity inducer to a subject in need thereof, said kit comprising:
(a) a topical patch preparation comprising:
(i) an adhesive gel composition comprising an effective amount of a delayed-type hypersensitivity inducer; and
(ii) a support; and
(b) instructions for using said preparation.
19 . The kit according to claim 18 , wherein said kit comprises a plurality of said topical patch preparations.
20 . The kit according to claim 19 , wherein said plurality of topical patch preparations are present in separate containers.
21 . The kit according to claim 20 , wherein said separate containers are sealed pouches.Join the waitlist — get patent alerts
Track US2004219199A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.